financetom
Business
financetom
/
Business
/
Nabors Industries Q2 Loss Widens, Revenue Declines
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nabors Industries Q2 Loss Widens, Revenue Declines
Jul 24, 2024 1:33 AM

04:14 AM EDT, 07/24/2024 (MT Newswires) -- Nabors Industries ( NBR ) reported late Tuesday a Q2 net loss of $4.29 per diluted share, wider than the $0.31 loss per share a year earlier.

Analysts polled by Capital IQ expected a loss of $1.37 per share.

Revenue and other income for the quarter ended June 30 was $743 million, down from $778.8 million a year earlier.

Price: 80.90, Change: -0.10, Percent Change: -0.12

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Preview: Viking Holdings Ltd Set To IPO Tomorrow
Preview: Viking Holdings Ltd Set To IPO Tomorrow
Apr 30, 2024
Viking Holdings Ltd (NYSE:VIK) IPO will take place May, 01 on the NYSE exchange under the ticker VIK. The company is offering shares at an expected price between $21.00 and $25.00 per share with an insider lock-up period of 180 days ending on October 28, 2024. See also: Benzinga IPO Calendar About Viking Holdings Ltd Viking a simple vision that...
Ecolab Gains After Beating Q1 Sales Expectations And Raising FY24 Outlook; Divests Surgical Segment For $950M
Ecolab Gains After Beating Q1 Sales Expectations And Raising FY24 Outlook; Divests Surgical Segment For $950M
Apr 30, 2024
Ecolab Inc. ( ECL ) shares are gaining on Tuesday after the company reported first-quarter results. The company reported quarterly adjusted earnings per share of $1.34, which is in line with the street view.  Quarterly sales of $3.752 billion beat the analyst consensus of $3.748 billion. Sales gained 5% year over year, led by strong growth in the Institutional & Specialty and Pest Elimination segments and modest Industrial segment growth....
Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer
Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer
Apr 30, 2024
11:16 AM EDT, 04/30/2024 (MT Newswires) -- Pfizer ( PFE ) and Genmab ( GMAB ) said Monday that the US Food and Drug Administration approved a supplemental biologics license application for Tivak to treat patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. The approval comes after the application received a priority review designation...
European Equities Traded in the US as American Depositary Receipts Decline
European Equities Traded in the US as American Depositary Receipts Decline
Apr 30, 2024
11:11 AM EDT, 04/30/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts fell Tuesday morning, down 0.5% to 1,373.3 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by food company Oatly ( OTLY ) and clinical-stage pharmaceutical company Addex Therapeutics ( ADXN ) , which rose 14% and 8.6%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved